Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peterson, B. A.
Right arrow Articles by Bloomfield, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peterson, B. A.
Right arrow Articles by Bloomfield, C. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents

Long-term disease-free survival in acute nonlymphocytic leukemia

BA Peterson and CD Bloomfield

Twenty-six of 45 adults (58%) with acute nonlymphocytic leukemia who were treated with intensive induction chemotherapy over 5 yr ago entered complete remission. All patients entering remission were placed on weekly maintenance chemotherapy consisting of cytosine arabinoside and 6-thioguanine. The median duration of complete remission was 17 mo and 7 patients (27%) remained in their initial remission for 62 + to 102 + mo. All but one of the patients in complete remission over 5 yr have had treatment discontinued. Only 1 of 7 patients in remission for more than 5 yr has relapsed. Median survival is 26.5 mo, and 8 patients (31%) currently remain alive without evidence of leukemia 63--105 mo from diagnosis. It is possible to achieve long-term disease-free survival with chemotherapy alone in acute nonlymphocytic leukemia.

Volume 57, Issue 6, pp. 1144-1147, 06/01/1981
Copyright © 1981 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 NEJMHome page
R. J. Mayer, R. B. Davis, C. A. Schiffer, D. T. Berg, B. L. Powell, P. Schulman, G. A. Omura, J. O. Moore, O. R. McIntyre, E. Frei, et al.
Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia
N. Engl. J. Med., October 6, 1994; 331(14): 896 - 903.
[Abstract] [Full Text]

Home page
 JAMAHome page
M. M. Bortin, R. P. Gale, H. E. M. Kay, and A. A. Rimm
Bone Marrow Transplantation for Acute Myelogenous Leukemia: Factors Associated With Early Mortality
JAMA, March 4, 1983; 249(9): 1166 - 1175.
[Abstract] [PDF]

Home page
 JAMAHome page
M. J. Keating, K. B. McCredie, G. P. Bodey, T. L. Smith, E. Gehan, and E. J Freireich
Improved Prospects for Long-term Survival in Adults With Acute Myelogenous Leukemia
JAMA, November 19, 1982; 248(19): 2481 - 2486.
[Abstract] [PDF]


click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1981 by American Society of Hematology         Online ISSN: 1528-0020